Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Methylation Status of Smg1 Gene Promoter in Multiple Myeloma



Gholipour H1 ; Abroun S1 ; Noruzinia M1 ; Ghaffari S2 ; Maali A3 ; Azad M4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematology Department, School of Medical Sciences, Tarbiat Modarres University, Tehran, Iran
  2. 2. Student Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medical Biotechnology, Faculty of medicine, Babol University of Medical Sciences, Babol, Iran
  4. 4. Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

Source: Iranian Journal of Blood and Cancer Published:2018

Abstract

Background: Epigenetic modifications, such as methylation can occur in multiple myeloma. SMG1is an important gene involved in cell growth which defect in methylation of its promoter leads to reduction of cell apoptosis and uncontrolled proliferation. In this study, we identified the methylation status of the SMG1 gene promoter in patients with multiple myeloma. Methods: Methylation status of SMG1 promoter in 9 patients with multiple myeloma and 4 healthy subjects as control was determined by Methylation-specific PCR (MSP) method. Results: SMG1 promoter in all myeloma patients was hemi-methylated. Meanwhile, in healthy subjects, two cases were hemi-methylated and the other two were normal. Conclusion: The results of this study indicated that the prevalence of SMG1 promoter methylation in patients with multiple myeloma was higher than general population which could be important in understanding the pathogenesis of the disease. © 2018, Iranian Pediatric Hematology and Oncology Society. All rights reserved.
Related Docs
1. Aberrant Dna Methylation Status and Mrna Expression Level of Smg1 Gene in Chronic Myeloid Leukemia: A Case-Control Study, Cell Journal (2022)
2. Methylation and Expression Status of the Cpg-Island of Smg1 Promoter in Acute Myeloid Leukemia: A Follow-Up Study in Patients, Cell Journal (2022)
Experts (# of related papers)
Saeed Mohammadi (1)
Shahrbano Rostami (1)